The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Update: Category 2 Removals Explained They Call It the 'Wolverine Peptide.' And Everyone from Biohackers to Your Dad Wants It Now. Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law